Brady Kelly (CIK 2117686) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-18). Recent activity: Buy MCRB (181 shares), Sell MCRB (64 shares), Buy MCRB (180 shares), Sell MCRB (59 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Operating Officer | Buy | 181 | $0 |
| 2026-08-18 | Seres Therapeutics, Inc. (MCRB) | EVP, Chief Operating Officer | Sell | 64 | $291 |
| 2026-05-19 | Seres Therapeutics, Inc. (MCRB) | Chief Operating Officer, EVP | Buy | 180 | $0 |
| 2026-05-19 | Seres Therapeutics, Inc. (MCRB) | Chief Operating Officer, EVP | Sell | 59 | $444 |
来源：SEC Form 4 申报文件 · 截至 2026-08-18